BioLife Solutions, Inc. Proceeds from Notes Payable
BioLife Solutions, Inc. (BLFS) reported Proceeds from Notes Payable of $1.00 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2018-05-11
- BioLife Solutions, Inc. proceeds from notes payable for the quarter ending 2017-03-31 was $1.00M.
- BioLife Solutions, Inc. proceeds from notes payable for the quarter ending 2016-03-31 was $0.00.
- BioLife Solutions, Inc. proceeds from notes payable for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. proceeds from notes payable for the quarter ending 2013-03-31 was $25.46K, a 85.45% decline year-over-year.
- BioLife Solutions, Inc. proceeds from notes payable for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- BioLife Solutions, Inc. proceeds from notes payable for fiscal 2012 was $475.00K, a 56.62% decline from fiscal 2011.
- BioLife Solutions, Inc. proceeds from notes payable for fiscal 2011 was $1.09M, a 4.37% decline from fiscal 2010.
- BioLife Solutions, Inc. proceeds from notes payable for fiscal 2010 was $1.15M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-11 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 | ||||
| 2014-06-30 | $80.59K 10-Q · filed 2014-08-07 | ||||
| 2013-12-31 | $0.00 10-K · filed 2014-02-12 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $25.46K 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2013-08-12 | $25.46K derived: sum of 3 quarters · filed 2014-08-07 | $25.46K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $25.46K 10-Q · filed 2014-05-08 | $25.46K derived: sum of 2 quarters · filed 2014-05-08 | $25.46K derived: sum of 3 quarters · filed 2014-05-08 | $325.46K derived: sum of 4 quarters · filed 2014-05-08 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | $0.00 derived: sum of 2 quarters · filed 2014-02-12 | $300.00K derived: sum of 3 quarters · filed 2014-02-12 | $475.00K 10-K · filed 2014-02-12 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $300.00K derived: sum of 2 quarters · filed 2013-11-14 | $475.00K 10-Q · filed 2013-11-14 | $700.00K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $475.00K 10-Q · filed 2013-08-12 | $700.00K derived: sum of 3 quarters · filed 2013-08-12 | $950.00K derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | $175.00K 10-Q · filed 2013-05-14 | $400.00K derived: sum of 2 quarters · filed 2013-05-14 | $650.00K derived: sum of 3 quarters · filed 2013-05-14 | $920.00K derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $475.00K derived: sum of 2 quarters · filed 2013-03-29 | $745.00K derived: sum of 3 quarters · filed 2013-03-29 | $1.09M 10-K · filed 2013-03-29 | |
| 2011-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $520.00K derived: sum of 2 quarters · filed 2012-11-13 | $870.00K 10-Q · filed 2012-11-13 | $1.17M derived: sum of 4 quarters · filed 2012-11-13 | |
| 2011-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $620.00K 10-Q · filed 2012-08-14 | $915.00K derived: sum of 3 quarters · filed 2012-08-14 | $1.17M derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $350.00K 10-Q · filed 2012-05-14 | $645.00K derived: sum of 2 quarters · filed 2012-05-14 | $895.00K derived: sum of 3 quarters · filed 2012-05-14 | ||
| 2010-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $545.00K derived: sum of 2 quarters · filed 2012-03-29 | $1.15M 10-K · filed 2012-03-29 | ||
| 2010-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $850.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $600.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |